絞り込み

16641

広告

「"Weinreb NJ"[Author]」の検索結果

61件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Neurochemical Abnormalities in Patients with Type 1 Gaucher Disease on Standard of Care Therapy.

Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Early Diagnosis Consensus (GED-C) Delphi initiative.

Hepatocellular carcinoma in Gaucher disease: an international case series.

Gaucher disease circa 2016: Progress and ongoing challenges.

Roscoe Owen Brady, MD: Remembrances of co-investigators and colleagues.

Causes of death in 184 patients with type 1 Gaucher disease from the United States who were never treated with enzyme replacement therapy.

Reduction of Plasma Globotriaosylsphingosine Levels After Switching from Agalsidase Alfa to Agalsidase Beta as Enzyme Replacement Therapy for Fabry Disease.

The history and accomplishments of the ICGG Gaucher registry.

Evaluation of disease burden and response to treatment in adults with type 1 gaucher disease using a validated disease severity scoring system (DS3).

The attenuated/late onset lysosomal storage disorders: Therapeutic goals and indications for enzyme replacement treatment in Gaucher and Fabry disease.

Enzyme replacement and substrate reduction therapy for Gaucher disease.

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease.

Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes.

Position statement: National gaucher foundation medical advisory board.

Oral small molecule therapy for lysosomal storage diseases.

Preface: Gaucher disease and cancer.

Causes of Death Due to Hematological and Non-Hematological Cancers in 57 US Patients with Type 1 Gaucher Disease Who Were Never Treated with Enzyme Replacement Therapy.

  1. 1
  2. 2
  3. 3
Sort by
※並べ替えは表示に時間がかかります